Evidence map›Paper›PMID 41791118›Full record

ArticleJMIR medical informatics2026

Leveraging Naturalistic Driving Digital Biomarkers for Early Mild Cognitive Impairment Detection: Deep Learning Strategies.

Firas Al-Hindawi, Teresa Wu, Yutong Wen, Peter Serhan, Erica Forzani, Francis Tsow, Yonas E Geda

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Firas Al-HindawiIndustrial & Systems Engineering Department, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.ORCID 0000-0002-3083-1775
Teresa WuSchool of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, United States.ORCID 0000-0002-0529-7048
Yutong WenSchool of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, United States.ORCID 0009-0000-9067-3679
Peter SerhanSchool of Electrical, Computer and Energy Engineering, Arizona State University, Tempe, AZ, United States.ORCID 0009-0005-8483-943X
Erica ForzaniCenter for Bioelectronics and Biosensors, Biodesign Institute, Arizona State University, Tempe, AZ, United States.ORCID 0000-0003-2407-8251
Francis TsowTF Health Corporation, Phoenix, AZ, United States.ORCID 0000-0002-3129-0624
Yonas E GedaBarrow Neurological Institute, Phoenix, AZ, United States.ORCID 0000-0003-1187-7230

Funding

Pathways linking neuropsychiatric symptoms with Alzheimer's disease neuroimaging biomarkers and the outcome of incident Mild Cognitive Impairment/ DementiaR01AG057708 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI GEDA, YONAS E · 2018 to 2022
$1.7M
Smart driving technology for non-invasive detection of age-related cognitive declineR44AG078063 · NIA · TF HEALTH CORPORATION · PI Erica Silvia Forzani, Francis Tsow · 2025 to 2026
$1.6M
Smart driving technology for non-invasive detection of age-related cognitive declineR43AG078063 · NIA · TF HEALTH CORPORATION · PI FORZANI, ERICA SILVIA, TSOW, FRANCIS · 2022 to 2022
$450k
NIA NIH HHS R01 AG057708NIA NIH HHS R43 AG078063NIA NIH HHS R44 AG078063
6 · The paper itself

Abstract

backgroundAlzheimer disease and related dementias are increasing worldwide, with early detection during the mild cognitive impairment (MCI) stage critical for timely intervention. Driving behavior, which reflects everyday cognitive functioning, has emerged as a promising, noninvasive, and inexpensive digital biomarker when paired with machine learning. However, prior research has often relied on controlled settings, high-level features, or assumptions that fail to capture the sporadic nature of MCI, leaving a gap in modeling naturalistic driving data for robust early detection.

objectiveThis study aims to address the limitations of prior work by developing deep learning strategies that leverage driving data collected in a naturalistic setting as digital biomarkers for early detection of MCI.

methodsClinically classified participants (8 with MCI and 14 cognitively normal; N=22) drove their personal vehicles under naturalistic conditions for several consecutive days. A total of 3 participants (2 cognitively normal and 1 MCI) withdrew before completing the experiments. In-vehicle sensors recorded GPS, accelerometer, and gyroscope signals, which were segmented into full trips and turning maneuvers. Three modeling strategies were compared: (1) single-view, (2) feature-level fusion, and (3) model-level late fusion. Classification models were trained and evaluated to assess their accuracy, discriminative ability, and participant-level performance.

resultsModels using full-trip data consistently outperformed turn-only inputs, with the best-performing model achieving 78% accuracy and an area under the receiver operating characteristic curve of 77%. Turn-based inputs alone demonstrated limited discriminative power; however, combining them with trip data through late fusion improved performance, though not beyond the full-trip baseline. Participant-level analysis indicated that classification accuracy improved with increased data volume, and trip-wise modeling more effectively captured the episodic nature of MCI than majority-vote aggregation. A frequency-based risk score was proposed as an interpretable and flexible output, enabling practical application in clinical and community settings.

conclusionsNaturalistic driving behavior offers a scalable and noninvasive approach for early cognitive screening. Deep learning models using full-trip naturalistic driving data show promise for detecting MCI, with fusion strategies providing supplementary insights. This framework supports proactive, real-world monitoring of cognitive decline, laying the foundation for digital health interventions in dementia prevention.

Indexed as

Automobile DrivingBiomarkersCognitive DysfunctionDeep LearningAgedDigital HealthEarly DiagnosisFemaleHumansMaleBiomarkersagingAlzheimer’s diseasedata fusiondeep learningmachine learningmild cognitive impairmentsmart driving

Identifiers

PMID41791118
PMCPMC13005058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.